Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng-Bo Han

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|April 3, 2004
[Quantitation and detection of deletion in tumor mitochondrial DNA by microarray technique]Cheng-bo Han, Yu-jie Zhao, Fan Li, et al.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|September 16, 2008
[Roles of angiopoietin-2, Tie-2 and hypoxia-inducible factor 1alpha in angiogenesis of glioma]Xiao-Han Li, Xiao-Song Wang, Cheng-Bo Han, et al.
Oncotargets and Therapy|August 16, 2016
Postoperative radiotherapy and tumor recurrence after complete resection of stage II/III thymic tumor: a meta-analysis of cohort studiesJietao Ma, Xin Sun, Letian Huang, et al.
The Tohoku Journal of Experimental Medicine|December 17, 2016
Meta-analysis Exploring the Effectiveness of S-1-Based Chemotherapy for Advanced Non-Small Cell Lung CancerXin Sun, Li Sun, Shu-Ling Zhang, et al.
Medicine|September 2, 2018
Efficacy and safety of apatinib in patients with advanced nonsmall cell lung cancer that failed prior chemotherapy or EGFR-TKIs: A pooled analysisJie-Tao Ma, Jing Sun, Li Sun, et al.
Molecular Medicine Reports|March 13, 2012
Altered expression of mitochondrial cytochrome c oxidase I and NADH dehydrogenase 4 transcripts associated with gastric tumorigenesis and tumor dedifferentiationJie-Tao Ma, Cheng-Bo Han, Yang Zhou, et al.
Translational Cancer Research|February 4, 2022
The influence of tumor heterogeneity on sensitivity of EGFR-mutant lung adenocarcinoma cells to EGFR-TKIsLi Sun, Yao-Yong Li, Jie-Tao Ma, et al.
World Journal of Gastroenterology|December 21, 2004
Quantitative analysis of tumor mitochondrial RNA using microarrayCheng-Bo Han, Xiao-Yun Mao, Yan Xin, et al.
Critical Reviews in Oncology/Hematology|July 17, 2025
Comparative efficacy of first-line therapies for PD-L1-negative advanced NSCLC: A network meta-analysis with reconstructed survival curvesJie-Tao Ma, Mei-Qi Yang, Shu-Ling Zhang, et al.
BMC Cancer|August 1, 2023
Rational application of EGFR-TKI adjuvant therapy in patients with completely resected stage IB-IIIA EGFR-mutant NSCLC: a systematic review and meta-analysis of 11 randomized controlled trialsShu-Ling Zhang, Xiao-Fang Yi, Le-Tian Huang, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|April 3, 2004
[Quantitation and detection of deletion in tumor mitochondrial DNA by microarray technique]Cheng-bo Han, Yu-jie Zhao, Fan Li, et al.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|September 16, 2008
[Roles of angiopoietin-2, Tie-2 and hypoxia-inducible factor 1alpha in angiogenesis of glioma]Xiao-Han Li, Xiao-Song Wang, Cheng-Bo Han, et al.
Oncotargets and Therapy|August 16, 2016
Postoperative radiotherapy and tumor recurrence after complete resection of stage II/III thymic tumor: a meta-analysis of cohort studiesJietao Ma, Xin Sun, Letian Huang, et al.
The Tohoku Journal of Experimental Medicine|December 17, 2016
Meta-analysis Exploring the Effectiveness of S-1-Based Chemotherapy for Advanced Non-Small Cell Lung CancerXin Sun, Li Sun, Shu-Ling Zhang, et al.
Medicine|September 2, 2018
Efficacy and safety of apatinib in patients with advanced nonsmall cell lung cancer that failed prior chemotherapy or EGFR-TKIs: A pooled analysisJie-Tao Ma, Jing Sun, Li Sun, et al.
Molecular Medicine Reports|March 13, 2012
Altered expression of mitochondrial cytochrome c oxidase I and NADH dehydrogenase 4 transcripts associated with gastric tumorigenesis and tumor dedifferentiationJie-Tao Ma, Cheng-Bo Han, Yang Zhou, et al.
Translational Cancer Research|February 4, 2022
The influence of tumor heterogeneity on sensitivity of EGFR-mutant lung adenocarcinoma cells to EGFR-TKIsLi Sun, Yao-Yong Li, Jie-Tao Ma, et al.
World Journal of Gastroenterology|December 21, 2004
Quantitative analysis of tumor mitochondrial RNA using microarrayCheng-Bo Han, Xiao-Yun Mao, Yan Xin, et al.
Critical Reviews in Oncology/Hematology|July 17, 2025
Comparative efficacy of first-line therapies for PD-L1-negative advanced NSCLC: A network meta-analysis with reconstructed survival curvesJie-Tao Ma, Mei-Qi Yang, Shu-Ling Zhang, et al.
BMC Cancer|August 1, 2023
Rational application of EGFR-TKI adjuvant therapy in patients with completely resected stage IB-IIIA EGFR-mutant NSCLC: a systematic review and meta-analysis of 11 randomized controlled trialsShu-Ling Zhang, Xiao-Fang Yi, Le-Tian Huang, et al.
Pageof 5